BioXtreme Announces CE Marking

BioXtreme is proud to announce that, following our ISO-13485 certification from the Israeli Standards Institution (www.sii.org.il), it has received its CE Marking, based on self declaration.

The CE Marking is intended for deXtreme, our upper limb neurorehabiliatation robotic device, meant to treat stroke and other TBI patients with our novel Error Enhancement technology. By this CE Marking we declare that deXtreme is compliant with EU standards for health, safety, and environmental protection.

The CE Marking, as well as the ongoing clinical trial in Heliomare rehabilitation hospital in the Netherlands marks an exciting new opportunity for BioXtreme, as our product is now eligible for selling in the entire European Economic Area.

About BioXtreme
BioXtreme Rehabilitation Robotics is instilling new dexterity for stroke and other neuro injuries patients. Using a patent-protected groundbreaking Error Enhancement technology, BioXtreme has developed a robotic system that helps with upper limb motor rehabilitation. Our product, deXtreme preforms automatic rebuild of motion range and capability through adaptive/intuitive learning. Based on unique robotic system that applies Error Enforcement forces, BioXtreme technology helps reprogramming the mind for extreme performance.